Nanomaterials in Drug Delivery System

  • Nur Izzati Mohd Razali
  • Noor Syazwani Mohd Saufi
  • Raha Ahmad RausEmail author
  • Wan Mohd Fazli Wan Nawawi
  • Dayang Fredalina Basri


Nanomaterial plays an important role in enhancing effective treatment of certain diseases nowadays. Owing to its near molecular-size scale, many pharmaceutical and biotechnology industries are now keen to use nanomaterials as their drug stabilizing agent as well as a vehicle to deliver their drug into a targeted site at a specific dosage with a controlled release time. Currently, the most studied and used nanomaterial in drug delivery is liposome, an amphipathic molecule that is able to carry both hydrophobic and hydrophilic drugs. Other nanomaterials such as chitosan, graphene-oxide, carbon nanotube, nanodiamond and mesoporous silica are also extensively studied to be used commercially due to their unique characteristics. These nanomaterials need first to be modified and functionalized to ensure effective treatment and reach the targeted site. In this review article, the characteristics and modification applied to these materials were elaborated and how these modifications enhance the treatment was also discussed.


  1. Arap W, Pasqualini R, Ruoslahti E (1998) Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279(5349):377–380CrossRefPubMedGoogle Scholar
  2. Bangham AD, Standish MM, Watkins JC (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13(1):IN26–IN27. Scholar
  3. Cao X, Tao L, Wen S, Hou W, Shi X (2015) Hyaluronic acid-modified multiwalled carbon nanotubes for targeted delivery of doxorubicin into cancer cells. Carbohydr Res 405:70–77. Scholar
  4. Chang L-Y, Ōsawa E, Barnard AS (2011) Confirmation of the electrostatic self-assembly of nanodiamonds. Nanoscale 3(3):958. Scholar
  5. Cevc G, Mazgareanu S, Rother M, Vierl U (2008) Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations. Int J Pharm 359(1–2):190–197. Scholar
  6. Chen M, Pierstorff ED, Lam R, Li SY, Huang H, Osawa E, Ho D (2009) Nanodiamond-mediated delivery of water-insoluble therapeutics. ACS Nano 3(7):2016–2022. Scholar
  7. Chen Y, Chen H, Shi J (2014) Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures. Expert Opin Drug Deliv 11(6):917–930. Scholar
  8. Desai C, Mitra S (2013) Microwave induced carboxylation of nanodiamonds. Diamond Relat Mater 34:65–69. Scholar
  9. Dineshkumar B, Krishnakumar K, Bhatt AR, Paul D, Cherian J, John A, Suresh S (2015) Single-walled and multi-walled carbon nanotubes based drug delivery system: cancer therapy: a review. Indian J Cancer 52(3):262–264. Scholar
  10. Dudhani AR, Kosaraju SL (2010) Bioadhesive chitosan nanoparticles: preparation and characterization. Carbohydr Polym 81(2):243–251. Scholar
  11. Eatemadi A, Daraee H, Karimkhanloo H, Kouhi M, Zarghami N, Akbarzadeh A et al (2014) Carbon nanotubes: properties, synthesis, purification, and medical applications. Nanoscale Res Lett 9(1):1–13. Scholar
  12. El Maghraby GM, Barry BW, Williams AC (2008) Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 34(4-5):203–222. Scholar
  13. Etzold BJM, Neitzel I, Kett M, Strobl F, Mochalin VN, Gogotsi Y (2014) Layer-by-layer oxidation for decreasing the size of detonation nanodiamond. Chem Mater 26(11):3479–3484. Scholar
  14. Geim AK (2009) Graphene: status and prospects. Science 324(5934):1530–1534. Scholar
  15. Grall R, Girard H, Saad L, Petit T, Gesset C, Combis-Schlumberger M et al (2015) Impairing the radioresistance of cancer cells by hydrogenated nanodiamonds. Biomaterials 61:290–298. Scholar
  16. He Q, Zhang Z, Gao F, Li Y, Shi J (2011) In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. Small 7(2):271–280. Scholar
  17. Hu H, Yu J, Li Y, Zhao J, Dong H (2012) Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery. J Biomed Mater Res A 100(1):141–148. Scholar
  18. Huang H, Pierstorff E, Osawa E, Ho D (2007) Active nanodiamond hydrogels for chemotherapeutic delivery. Nano Lett 7(11):3305–3314CrossRefPubMedGoogle Scholar
  19. Hussain A, Singh S, Sharma D, Webster TJ, Shafaat K, Faruk A (2017) Elastic liposomes as novel carriers: recent advances in drug delivery. Int J Nanomedicine 12:5087–5108. Scholar
  20. Iijima S (1991) Helical microtubules of graphitic carbon. Nature 354(6348):56–58CrossRefGoogle Scholar
  21. Jeong YI, Jin SG, Kim IY, Pei J, Wen M, Jung TY et al (2010) Doxorubicin-incorporated nanoparticles composed of poly(ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro. Colloids Surf B Biointerfaces 79(1):149–155. Scholar
  22. Klibanov AL, Maruyama K, Torchilin VP, Huang L (1990) Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268(1):235–237. Scholar
  23. Kresge C, Leonowicz ME, Roth WJ, Vartuli J, Beck JS (1992) Ordered mesoporous molecular-sieves synthesised by a liquid-crystal template mechanism. Nature 359(6397):710–712. Scholar
  24. Krüger A, Liang Y, Jarre G, Stegk J (2006) Surface functionalisation of detonation diamond suitable for biological applications. J Mater Chem 16(24):2322–2328. Scholar
  25. Kreuter J (1994) Nanoparticles. In: Swarbrick J, Boylan JC (eds) Encyclopaedia of pharmaceutical technology. New York, Marcel Dekker, pp 165–190Google Scholar
  26. Kuroda K (n.d.) Mesoscale materials design utilizing layered materials. Retrieved from
  27. Lamprecht A, Ubrich N, Yamamoto H, Schäfer U, Takeuchi H, Maincent P, Kawashima Y, Lehr CM (2001) Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J Pharmacol Exp Ther 299:775–781PubMedGoogle Scholar
  28. Leamon CP, Reddy JA (2004) Folate-targeted chemotherapy. Adv Drug Deliv Rev 56:1127–1141CrossRefPubMedGoogle Scholar
  29. Li J, Wang X, Zhang T, Wang C, Huang Z, Luo X, Deng Y (2015) A review on phospholipids and their main applications in drug delivery systems. Asian J Pharm Sci 10(2):81–98. Scholar
  30. Liang Y, Meinhardt T, Jarre G, Ozawa M, Vrdoljak P, Schöll A et al (2011) Deagglomeration and surface modification of thermally annealed nanoscale diamond. J Colloid Interface Sci 354(1):23–30. Scholar
  31. Lim DG, Prim RE, Kim KH, Kang E, Park K, Jeong SH (2016) Combinatorial nanodiamond in pharmaceutical and biomedical applications. Int J Pharm 514(1):41–51. Scholar
  32. Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z (2008) Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev 60(15):1650–1662. Scholar
  33. Liu KK, Zheng WW, Wang CC, Chiu YC, Cheng CL, Lo YS et al (2010) Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy. Nanotechnology 21(31):315106. Scholar
  34. Liu Z, Robinson JT, Tabakman SM, Yang K, Dai H (2011) Carbon materials for drug delivery & cancer therapy. Mater Today 14(7–8):316–323. Scholar
  35. Liu J, Cui L, Losic D (2013) Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater 9(12):9243–9257. Scholar
  36. Lu J, Liong M, Li Z, Zink JI, Tamanoi F (2010) Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 6(16):1794–1805. Scholar
  37. Maeda Y, Kimura Y (2004) Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice. J Nutr 134(4):945–950CrossRefPubMedGoogle Scholar
  38. Malhotra BD, Srivastava S, Augustine S (2015) Biosensors for food toxin detection: carbon nanotubes and graphene. MRS Online Proceedings Library Archive 1725Google Scholar
  39. Mamaeva V, Sahlgren C, Lindén M (2013) Mesoporous silica nanoparticles in medicine—recent advances. Adv Drug Deliv Rev 65(5):689–702. Scholar
  40. Mansuri S, Kesharwani P, Jain K, Tekade RK, Jain NK (2016) Mucoadhesion: a promising approach in drug delivery system. React Funct Polym 100:151–172. Scholar
  41. Mao S, Sun W, Kissel T (2010) Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev 62(1):12–27. Scholar
  42. Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy – mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46(12 Pt 1):6387–6392PubMedGoogle Scholar
  43. Milla P, Dosio F, Cattel L (2012) PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery. Curr Drug Metab 13(1):105–119. Scholar
  44. Mitev D, Dimitrova R, Spassova M, Minchev C, Stavrev S (2007) Surface peculiarities of detonation nanodiamonds in dependence of fabrication and purification methods. Diamond Relat Mater 16(4–7):776–780. Scholar
  45. Mitev DP, Townsend AT, Paull B, Nesterenko PN (2014) Microwave-assisted purification of detonation nanodiamond. Diamond Relat Mater 48:37–46. Scholar
  46. Mochalin VN, Shenderova O, Ho D, Gogotsi Y (2012) The properties and applications of nanodiamonds. Nat Nanotechnol 7(1):11–23. Scholar
  47. Moon HK, Lee SH, Choi HC (2009) In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano 3(11):3707–3713. Scholar
  48. Nagpal K, Singh SK, Mishra DN (2010) Chitosan nanoparticles: a promising system in novel drug delivery. Chem Pharm Bull 58(11):1423–1430. Scholar
  49. Osswald S, Yushin G, Mochalin V, Kucheyev SO, Gogotsi Y (2006) Control of sp2/sp3 carbon ratio and surface chemistry of nanodiamond powders by selective oxidation in air. J Am Chem Soc 128(35):11635–11642. Scholar
  50. Osswald S, Havel M, Mochalin V, Yushin G, Gogotsi Y (2008) Increase of nanodiamond crystal size by selective oxidation. Diamond Relat Mater 17(7–10):1122–1126. Scholar
  51. Pan Y, Sahoo NG, Li L (2012) The application of graphene oxide in drug delivery. Expert Opin Drug Deliv 9(11):1365–1376. Scholar
  52. Panchapakesan B, Lu S, Sivakumar K, Teker K, Cesarone G, Wickstrom E (2005) Single-wall carbon nanotube nanobomb agents for killing breast cancer cells. Nanobiotechnology 1(2):133–139. Scholar
  53. Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55:329–347CrossRefPubMedGoogle Scholar
  54. Petrov I, Shenderova O, Grishko V, Grichko V, Tyler T, Cunningham G, McGuire G (2007) Detonation nanodiamonds simultaneously purified and modified by gas treatment. Diamond Relat Mater 16(12):2098–2103. Scholar
  55. Pichot V, Comet M, Fousson E, Baras C, Senger A, Le Normand F, Spitzer D (2008) An efficient purification method for detonation nanodiamonds. Diamond Relat Mater 17(1):13–22. Scholar
  56. Pires A, Fortuna A, Alves G, Falcão A (2009) Intranasal drug delivery: how, why and what for? J Pharm Pharm Sci 12(3):288–311. Scholar
  57. Cullis PR, De Kruijff B (1979) Lipid polymorphism and the functional roles of lipids in biological membranes. Biochim Biophys Acta 559(4):399e420CrossRefGoogle Scholar
  58. Safari J, Zarnegar Z (2014) Advanced drug delivery systems: nanotechnology of health design A review. J Saudi Chem Soc 18(2):85–99. Scholar
  59. Sahoo NG, Bao H, Pan Y, Pal M, Kakran M, Cheng HKF et al (2011) Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study. Chem Commun (Camb) 47(18):5235–5237. Scholar
  60. Shenderova O, Petrov I, Walsh J, Grichko V, Grishko V, Tyler T, Cunningham G (2006) Modification of detonation nanodiamonds by heat treatment in air. Diamond Relat Mater 15(11–12):1799–1803. Scholar
  61. Singh R, Lillard JW (2009) Nanoparticle-based targeted drug delivery. Exp Mol Pathol 86(3):215–223. Scholar
  62. Sinha R, Kim GJ, Nie S, Shin DM (2006) Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther 5(8):1909–1917CrossRefPubMedGoogle Scholar
  63. Sudimack J, Lee RJ (2000) Drug targeting via the folate receptor. Adv Drug Deliv Rev 41:147–162CrossRefPubMedGoogle Scholar
  64. Sushchev VG, Dolmatov VY, Marchukov VA, Veretennikova MV (2008) Fundamentals of chemical purification of detonation nanodiamond soot using nitric acid. J Superhard Mater 30(5):297–304. Scholar
  65. Svenson S, Tomalia DA (2005) Dendrimers in biomedical applications—reflections on the field. Adv Drug Deliv Rev 57(15):2106–2129. Scholar
  66. Torney F, Trewyn BG, Lin VSY, Wang K (2007) Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat Nanotechnol 2(5):295–300. Scholar
  67. Torzsas TL, Kendall CWC, Sugano M, Iwamoto Y, Rao AV (1996) The influence of high and low molecular weight chitosan on colonic cell proliferation and aberrant crypt foci development in CF1 mice. Food Chem Toxicol 34(1):73–77. Scholar
  68. Turcheniuk K, Mochalin VN (2017) Biomedical applications of nanodiamond (Review). Nanotechnology 28(25):252001. Scholar
  69. Vabbilisetty P, Sun XL (2014) Liposome surface functionalization based on different anchoring lipids via Staudinger ligation. Org Biomol Chem 12(8):1237. Scholar
  70. Vallet-Regi M, Rámila A, Del Real RP, Pérez-Pariente J (2001) A new property of MCM-41: drug delivery system. Chem Mater 13(2):308–311. Scholar
  71. Vallet-Regi M, Balas F, Arcos D (2007) Mesoporous materials for drug delivery. Angew Chem Int Ed Engl 46(40):7548–7558. Scholar
  72. Wang JJ, Zeng ZW, Xiao RZ, Xie T, Zhou GL, Zhan XR, Wang SL (2011) Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine 6:765–774PubMedPubMedCentralGoogle Scholar
  73. Wen H, Dong C, Dong H, Shen A, Xia W, Cai X, Song Y, Li X, Li Y, Shi D (2012) Engineered redox-responsive PEG detachment mechanism in PEGylated nano-graphene oxide for intracellular drug delivery. Small 8(5):760–769. Scholar
  74. Whitlow J, Pacelli S, Paul A (2017) Multifunctional nanodiamonds in regenerative medicine: recent advances and future directions. J Control Release 261:62–86. Scholar
  75. Wilczewska A, Niemirowicz K, Markiewicz K, Car H (2012) [Review] Nanoparticles as drug delivery systems. Pharmacol Rep 64(5):1864–1882. Scholar
  76. Wong BS, Yoong SL, Jagusiak A, Panczyk T, Ho HK, Ang WH, Pastorin G (2013) Carbon nanotubes for delivery of small molecule drugs. Adv Drug Deliv Rev 65(15):1964–2015. Scholar
  77. Yang Y, Zhang YM, Chen Y, Zhao D, Chen JT, Liu Y (2012) Construction of a graphene oxide based noncovalent multiple nanosupramolecular assembly as a scaffold for drug delivery. Chem A Eur J 18(14):4208–4215. Scholar
  78. Yanagisawa T, Shimizu T, Kuroda K, Kato C (1990) The preparation of alkyltrimethylammonium-kanemite complexes and their conversion to microporous materials. Bull Chem Soc Jpn 63(4):988–992. Scholar
  79. Zareie HM, Boyer C, Bulmus V, Nateghi E, Davis TP (2008) Temperature-responsive self-assembled monolayers of oligo(ethylene glycol): control of biomolecular recognition. ACS Nano 2(4):757–765. Scholar
  80. Zhang L, Lu Z, Zhao Q, Huang J, Shen H, Zhang Z (2011) Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide. Small 7(4):460–464. Scholar
  81. Zhang N, Li J, Jiang W, Ren C, Li J, Xin J, Li K (2010) Effective protection and controlled release of insulin by cationic β-cyclodextrin polymers from alginate/chitosan nanoparticles. Int J Pharm 393(1–2):213–219. Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Nur Izzati Mohd Razali
    • 1
  • Noor Syazwani Mohd Saufi
    • 1
  • Raha Ahmad Raus
    • 1
    Email author
  • Wan Mohd Fazli Wan Nawawi
    • 1
  • Dayang Fredalina Basri
    • 2
  1. 1.Department of Biotechnology Engineering, Faculty of EngineeringInternational Islamic University of MalaysiaJalan GombakMalaysia
  2. 2.Biomedical Science Programme, School of Diagnostic & Applied Health Sciences, Faculty of Health SciencesUniversiti Kebangsaan MalaysiaKuala LumpurMalaysia

Personalised recommendations